Overview
- Actions of endocannabinoids on various physiological systems
- Recent developments in natural cannabis-based medicine
- New therapeutic insights into a large number of diseases
- Includes supplementary material: sn.pub/extras
Part of the book series: Milestones in Drug Therapy (MDT)
Buy print copy
About this book
In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most volumes published on cannabinoids so far concentrate on the biological activity, biochemistry and pharmacology, whereas this volume concentrates on the diseases, the physiological effects and therapeutic use of cannabinoids. The volume editor Prof. Mechoulam was the first who isolated the prime active constituent (THC, Tetrahydrocannabiol) of marijuana. He published extensively on the pharmacological activities of cannabinoids. The volume is of interest to researchers and clinicians from pharmacology, neuroscience, and medicinal research.
Keywords
Table of contents (14 chapters)
-
Front Matter
-
Back Matter
Editors and Affiliations
Bibliographic Information
Book Title: Cannabinoids as Therapeutics
Editors: Raphael Mechoulam
Series Title: Milestones in Drug Therapy
DOI: https://doi.org/10.1007/3-7643-7358-X
Publisher: Birkhäuser Basel
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Birkhäuser Basel 2005
Hardcover ISBN: 978-3-7643-7055-8Published: 19 May 2005
eBook ISBN: 978-3-7643-7358-0Published: 30 March 2006
Series ISSN: 2296-6056
Series E-ISSN: 2296-6064
Edition Number: 1
Number of Pages: X, 268
Topics: Pharmacology/Toxicology, Human Physiology, Neurosciences, Neurology, Psychiatry